The degradation of the acetylcholinesterase and butyrylcholinesterase would lead to the consequent release of acetylcholine that binds back to the nicotinic and muscarinic receptors, could accelerate their proliferation, migration, and invasion of the lung cancer cells15, in both the carcinogenesis and progression of lung cancer. The gene discussed is ACHE; the disease is lung cancer.